Extensive biochemical testing and 16S rRNA and rpoB sequence analysis revealed that clinical strain CF01Ent1, initially identified as Buttiauxella agrestis by the use of Api 32 biochemical strips, is a new organism in the Enterobacteriaceae family. It produced an inducible AmpC-type ␤-lactamase whose sequence shares 69 to 72% identity with those of the other AmpC-type ␤-lactamases of Enterobacteriaceae. This enzyme exhibits an atypical high affinity for all ␤-lactams tested.
In 1998, we isolated from a wound of a patient hospitalized in the intensive care ward at the teaching hospital of ClermontFerrand, France, an unusual strain of Enterobacteriaceae, designated CF01Ent1 and initially identified (by use of Api32E biochemical strips [BioMerieux] ) with a probability of 99.7% as Buttiauxella agrestis, a species not usually recovered from human specimens (4, 11, 15) . Extensive biochemical testing, which was performed with biotype-100 carbon source strips (BioMérieux), failed to identify the isolate strain as belonging to a known species, the closest being Klebsiella pneumoniae (isolate strain test results diverging from those for Klebsiella pneumoniae: negative reactions for D-melibiose, D-raffinose, palatinose, and myo-inositol).
The 16S rRNA sequence of the organism was determined as previously reported (16) and compared (using Clustal software) with more than 222 16S rRNA sequences downloaded from GenBank ( Fig. 1 ) or determined at Institut Pasteur. The tree constructed from this alignment, using neighbor-joining methods implemented by Lasergene software (DNAstar, Madison, Wis.), showed that the sequence was distinct from those of members of the branches containing species of genera Klebsiella, Buttiauxella, Kluyvera, and Citrobacter. The branching of strain CF01Ent1 differed according to the identity of the species selected for building the tree. The proximity with the Cedecea species shown in Fig. 1 was inconstant. These results were confirmed by the analysis of rpoB sequences (data not shown) (10) . Using the results of the biochemical testing and 16S rRNA and rpoB sequencing, therefore, the isolated strain, which was designated CF01Ent1, was identified as the single representative of a new species of the family Enterobacteriaceae, which may be described more fully later, when other, similar isolates are collected. Although commercial microbial identification systems provide accurate identification of the common species of Enterobacteriaceae, this result shows that they are problematic with newly described organisms.
MICs for strain CF01Ent1 were determined on MuellerHinton agar with an inoculum of 10 4 CFU per spot by a dilution method (Sanofi Diagnostics Pasteur, Marnes la Coquette, France) (1). The ␤-lactam resistance phenotype (Table  1) was characterized by resistance to amoxicillin (MIC of 32 g/ml), cephalothin (64 g/ml), and cefoxitin (32 g/ml) and, to a lesser extent, to cefuroxime (8 g/ml). Clavulanate (2 g/ml) did not restore susceptibility to amoxicillin (MIC, 32 g/ml). In contrast, the enteric bacterium CF01Ent1 was susceptible to ticarcillin, piperacillin, cefotaxime, ceftazidime, aztreonam, cefepime, cefpirome, and imipenem (MICs, 0.06 to 2 g/ml). From a cell extract of strain CF01Ent1, one protein band of isoelectric point 9.2 had ␤-lactamase activity in analytical isoelectric focusing experiments, which were performed as previously reported (2) .
The ␤-lactam resistance phenotype and the isoelectric point suggest the production of a class C cephalosporinase (3), but negative amplification tests were obtained with primers designed to amplify class C ␤-lactamase-encoding genes of Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae, Citrobacter freundii, Morganella morganii, and Serratia marcescens. Cloning was undertaken in pBK-CMV vector (Stratagene, La Jolla, Calif.) with genomic DNA partially restricted with Sau3A, as previously reported (12) . Two transformants harboring the recombinant plasmids pCF01Ent1-3 and pCF01Ent1-8 produced the ␤-lactamase of clinical strain CF01Ent1. Except for that of imipenem, the ␤-lactam MICs for the transformants were higher than those for the strain CF01Ent1 (Table 1) .
To determine whether the ␤-lactamase gene was inducible, the specific ␤-lactamase activities of clinical strain CF01Ent1 and of the E. coli transformants were measured after induction for 2 h with cefoxitin at 16 g/ml. Cell extracts of the induced E. coli transformant (pCF01Ent1-8) and induced strain CF01Ent1 had about 30-fold higher specific activities (148.0 Ϯ 6 and 70.0 Ϯ 2 U/mg of protein, respectively) than extracts from uninduced cultures (5.0 Ϯ 0.6 and 2.5 Ϯ 0.5 U/mg of protein, respectively). These results show that ␤-lactamase expression is inducible in strain CF01Ent1 and in the E. coli transformant (pCF01AB1-8). Chromosomal class C ␤-lacta- mases are generally regulated by a trans-acting protein, AmpR, which represses or induces the transcription of the ampC gene in the absence or in the presence of inducer, respectively (5, 8, 14) . In contrast, cell extracts of induced and uninduced E. coli harboring pCF01Ent1-3 had higher and similar specific activities (1,245.0 Ϯ 10 and 1,516.5 Ϯ 15 U/mg of protein, respectively). As a result of the alteration of the ␤-lactamase regulon in the recombinant plasmid pCF01Ent1-3, the ␤-lactamase expression is not repressed in this E. coli transformant, a finding similar to that for natural plasmid-encoded class C ␤-lactamases (8, 9) .
Recombinant plasmids pCF01Ent1-3 and pCF01Ent1-8, which harbor inserts of 3.5 and 8 kb, respectively, were used to sequence the ␤-lactamase gene of the clinical isolate by the dideoxy chain termination procedure of Sanger et al. (13) . The sequence revealed an ampC-type ␤-lactamase gene downstream of, and oppositely oriented to, the sequence of a typical ampR regulator gene (Fig. 2) , as previously reported for the chromosome-mediated class C ␤-lactamases genes (5, 8, 14) . The 86-bp ampR-ampC intercistronic region contained two overlapping and divergently oriented promoters as well as a Lys-R-type sequence, which was probably the fixation site of AmpR protein. As plasmid pCF01BA1-3 contained a partial 234-bp AmpR-encoding gene, the complete sequence of the ampR gene was obtained by sequencing plasmid pCF01Ent1-8. The deduced amino acid sequence of the 873-bp AmpR-type open reading frame was 81 to 85% identical to the known AmpR-type protein and harbored a helix-turn-helix motif, which is typical of transcriptional activators of the Lys-R family, as observed in other AmpR proteins (5, 14) .
The 1,194-bp-long AmpC-type type open reading frame encoded a 390-amino acid sequence, which contained the consensus sites SXXK, YAN, and KTG of class C ␤-lactamases (6). Analysis of this precursor protein suggested that the leader peptide comprised 20 residues. The molecular mass and pI of the deduced mature protein were 39,822 kDa and 9.26, respectively, which is in agreement with the experimental pI value.
The AmpC-type ␤-lactamase was compared with 25 other chromosomally encoded and plasmid-encoded class C cephalosporinases (data not shown). Plasmid-mediated class C cephalosporinases have about 87 to 99% identity with the chromosomally encoded class C ␤-lactamases of C. freundii (LAT group and CMY-2 to CMY-7), E. cloacae, Enterobacter asburiae (MIR-1 and ACT-1), and Hafnia alvei (ACC-1) and therefore probably originate from these species by transfer of their ␤-lactamase genes into plasmids. The plasmid-encoded enzymes MOX-2, FOX-1, CMY-1, and CMY-8 to CMY-11 are only distantly related (Ͻ75% identity) to the known chromosomally encoded class C ␤-lactamases and are therefore "or- on September 7, 2017 by guest http://aac.asm.org/ phans." AmpC ␤-lactamase of strain CF01Ent1, designated Ent-1, was only about 40% identical to these orphan plasmidmediated class C cephalosporinases and therefore cannot be the origin of the plasmidic class C ␤-lactamases. The most closely related class C ␤-lactamases were from the genus Enterobacter, with about 70% identity (and from that corresponding to the unpublished GenBank sequence no. AJ415568, with 98% identity). The phylogenic tree (Fig. 3) , which was constructed as previously reported (2), showed that the class C cephalosporinase of strain CF01Ent1 clustered with chromosomally mediated class C ␤-lactamases of Enterobacteriaceae, between those of a species group comprising E. coli, C. freundii, and E cloacae and that of Yersinia enterocolitica (69 to 70% and 51% identity, respectively). The kinetic constants of the ␤-lactamase were obtained with partially purified extracts as reported previously (7) ( Table 2 ). The best substrates of this ␤-lactamase were benzylpenicillin (relative maximum rate of hydrolysis [V max ], 100%), cephalothin (relative V max , 130%) and cefazolin (relative V max , 770%), and no hydrolysis was detected for ticarcillin and piperacillin, which are expanded-and broad-spectrum cephalosporins, respectively. Except for cephalothin (K m , 80 M), the affinity of the ␤-lactamase for all substrates (K i and K m , 0.05 to 20 M) was higher than those previously reported for AmpC-type ␤-lactamases (3). This difference could be explained by a very low deacylation step during the hydrolysis of the substrates.
We characterized a new inducible AmpC-type ␤-lactamase from a clinical isolate of a new member of the Enterobacteriaceae family. Its enzymatic properties were characterized by a high affinity for all substrates and weak hydrolytic activity.
Nucleotide sequence accession number. The ampR-ampC, rpoB, and 16S rRNA sequences are listed under GenBank accession no. AF440406, AJ489827, and AJ489826, respectively.
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